ir.biocept.comInvestor Relations | Biocept Inc.
ir.biocept.com Profile
ir.biocept.com
Maindomain:biocept.com
Title:Investor Relations | Biocept Inc.
Description:The Investor Relations website contains information about Biocept Inc.'s business for stockholders, potential investors, and financial analysts.
Discover ir.biocept.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
ir.biocept.com Information
Website / Domain: |
ir.biocept.com |
HomePage size: | 52.619 KB |
Page Load Time: | 0.524347 Seconds |
Website IP Address: |
23.194.131.139 |
Isp Server: |
Akamai Technologies Inc. |
ir.biocept.com Ip Information
Ip Country: |
United States |
City Name: |
Ashburn |
Latitude: |
39.043720245361 |
Longitude: |
-77.487487792969 |
ir.biocept.com Keywords accounting
ir.biocept.com Httpheader
Accept-Ranges: bytes |
Content-Encoding: gzip |
Content-Language: en |
Content-Type: text/html; charset=UTF-8 |
device: desktop |
ETag: "1615179275" |
Expect-CT: max-age=0, report-uri="/report-expect-ct-violation" |
Feature-Policy: "accelerometer none;ambient-light-sensor none;autoplay self;camera none;encrypted-media none;fullscreen self;geolocation self;gyroscope none;magnetometer none;microphone none;midi none;payment none;picture-in-picture none;speaker self;sync-xhr self;usb none;vibrate none;vr none", From-Origin: same |
Last-Modified: Mon, 08 Mar 2021 04:54:35 GMT |
Link: http://ir.biocept.com/; rel="shortlink", http://ir.biocept.com/; rel="canonical", https://ir.biocept.com/investor-relations; rel="alternate"; hreflang="en", https://ir.biocept.com/investor-relations; rel="revision" |
Referrer-Policy: no-referrer-when-downgrade |
X-Age: 0 |
X-Content-Type-Options: nosniff |
X-Drupal-Dynamic-Cache: UNCACHEABLE |
X-Frame-Options: SAMEORIGIN |
X-Request-ID: v-613f62fc-7fca-11eb-b826-1b0cb8b1af18 |
X-UA-Compatible: IE=edge |
X-XSS-Protection: 1; mode=block |
Content-Length: 12534 |
X-EdgeConnect-MidMile-RTT: 0, 0 |
X-EdgeConnect-Origin-MEX-Latency: 469, 469 |
Cache-Control: public, max-age=0, s-maxage=2700 |
Expires: Mon, 08 Mar 2021 04:54:36 GMT |
Date: Mon, 08 Mar 2021 04:54:36 GMT |
Connection: keep-alive |
Vary: Accept-Encoding |
Set-Cookie: DrupalVisitorMobile=0; path=/; Secure; HttpOnly |
Strict-Transport-Security: max-age=15768000 ; preload |
ir.biocept.com Meta Info
charset="utf-8"/ |
content="Biocept Inc." property="og:site_name"/ |
content="website" property="og:type"/ |
content="The Investor Relations website contains information about Biocept Inc.'s business for stockholders, potential investors, and financial analysts." name="description"/ |
content="https://ir.biocept.com/investor-relations" property="og:url"/ |
content="Investor Relations | Biocept Inc." property="og:title"/ |
content="no-referrer" name="referrer"/ |
content="The Investor Relations website contains information about Biocept Inc.'s business for stockholders, potential investors, and financial analysts." property="og:description"/ |
content="Drupal 8 (https://www.drupal.org)" name="Generator"/ |
content="width" name="MobileOptimized"/ |
content="true" name="HandheldFriendly"/ |
content="width=device-width, initial-scale=1.0" name="viewport"/ |
23.194.131.139 Domains
ir.biocept.com Similar Website
Domain |
WebSite Title |
nelnetinvestors.com | Nelnet Inc - Investor Resources - Investor Services Program |
parkerdrilling.investorroom.com | Exantas Investor Relations - Investor Overview |
investor.wgo.net | Winnebago Investor Relations Investor Home |
investor.choicehotels.com | Choice Hotels International - Investor Relations Home - Investor Relations |
uti.investorroom.com | Universal Technical Institute's Investor Relations - UTI Investor Relations |
eqbank.investorroom.com | Equitable Bank Investor Relations - Investor Relations - Overview |
ir.americanexpress.com | Investor Relations - American Express Investor Relations |
51talk.investorroom.com | 51Talk Investor Relations - Investor Relations Home |
ir.armstrong.com | Armstrong World Industries Investor Relations | Armstrong Flooring Investor Relations |
lankaninvestor.com | Lankan Investor - Lankan Investor - Home |
investor.littelfuse.com | Investor Relations | Investor Relations | Littelfuse |
nexgenprofitmultiplier.investorplace.com | Matt McCall's Early Stage Investor Account : Matt McCall's Early Stage Investor |
ir.monolithicpower.com | Investor Relations |
58.investorroom.com | 58.com Investor Relations - Welcome |
client.hallequitiesgroup.com | HEG Investor : HEG Investor |
ir.biocept.com Traffic Sources Chart
ir.biocept.com Alexa Rank History Chart
ir.biocept.com Html To Plain Text
Skip to main navigation Technology Investor Relations Company Careers Customer Service Navigation Patients/Caregivers Medical Professionals Partners Investor Relations Investor Relations Overview Press Releases Events & Presentations Financial Information Stock Information Corporate Governance Investor FAQs Contact Us Shareholder Tools Email Alerts Subscription Download Library Print Share Facebook LinkedIn Twitter RSS Investor Relations Biocept, Inc. is a molecular diagnostics company with commercialized assays for lung, breast, gastric, colorectal and prostate cancers, and melanoma. The Company leverages its proprietary liquid biopsy technology to provide physicians with clinically actionable information for treating and monitoring patients diagnosed with cancer. Biocept’s patented Target Selector™ liquid biopsy technology platform captures and analyzes tumor-associated molecular markers in both circulating tumor cells (CTCs) and in circulating tumor DNA (ctDNA). With thousands of tests performed, the platform has demonstrated the ability to identify cancer mutations and alterations to inform physicians about a patient’s disease and therapeutic options. There are no items to display. Intra 3 mo. 6 mo. 1 yr. Press Releases Mar 3, 2021 Summary Toggle Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Mar 2, 2021 Summary Toggle Aegea Biotechnologies Announces Supply Agreement with Biocept for New COVID-19 Test with the Ability to Distinguish Virus Strains and Quantify Viral Load View all press releases » Events & Presentations Mar 1, 2021 Corporate Presentation View Presentation 1.4 MB Jan 11, 2021 at 6:00 AM EST H.C. Wainwright Virtual BioConnect Conference Listen to Webcast View all events & presentations » Investor Relations Company Careers Customer Service Contact Biocept, Inc. Biocept, Inc. Headquarters 9955 Mesa Rim Road San Diego, CA 92121 Phone: 858.320.8200 Fax: 858.320.8225 Email: IR@biocept.com LHA Investor Relations Jody Cain 310.691.7107 jcain@lhai.com Connect With Us Important Links Patients/Caregivers | Medical Professionals | Partners | Contact Us Careers Company Customer Service Technology Privacy Policy Terms of Use Contact Us © 2021 Biocept, Inc. All rights reserved....
ir.biocept.com Whois
"domain_name": "BIOCEPT.COM",
"registrar": "Network Solutions, LLC",
"whois_server": "whois.networksolutions.com",
"referral_url": null,
"updated_date": "2020-02-24 17:46:27",
"creation_date": "2000-02-21 08:07:06",
"expiration_date": "2022-02-21 08:07:06",
"name_servers": [
"NS7.WORLDNIC.COM",
"NS8.WORLDNIC.COM"
],
"status": "clientTransferProhibited https://icann.org/epp#clientTransferProhibited",
"emails": "abuse@web.com",
"dnssec": "unsigned",
"name": null,
"org": null,
"address": null,
"city": null,
"state": null,
"zipcode": null,
"country": null